Topic
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
2 Podcasts on BackTable
Hear how experienced physicians manage Metastatic Castration-Resistant Prostate Cancer (mCRPC) on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 303 • 19 May 2026
PARP Inhibitors: Clinical Trials & Real-World Applications
Keeping patients on PARP inhibitors long enough to see real benefit often comes down to proactive side effect management. In this episode of BackTable Urology, Dr. Neeraj Agarwal and Dr. Arun Azad join host Dr. Alan Tan to discuss practical, evidence-based strategies for managing hematologic and GI toxicities in advanced prostate cancer patients receiving PARP inhibitors.
This podcast is supported by an educational grant from Pfizer.
More on Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Loading recent podcasts…
Urology Episode #303
May 19, 2026
with Dr. Neeraj Agarwal, Dr. Arun Azad, Dr. Alan Tan
Keeping patients on PARP inhibitors long enough to see real benefit often comes down to proactive side effect...
Tumor Board Episode #60
May 19, 2026
with Dr. Neeraj Agarwal, Dr. Arun Azad, Dr. Alan Tan
Keeping patients on PARP inhibitors long enough to see real benefit often comes down to proactive side effect...
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.